Vijaya Diagnostic Reports Q2 Revenue of ₹2.55 Billion vs ₹2.02 Billion YoY

Market snapshot: Vijaya Diagnostic Centre Limited declared its Q2 financial performance, recording top-line revenue of ₹255 crore compared to ₹202 crore in the corresponding period of the previous year. This reflects a solid year-on-year revenue expansion of approximately 26.24%.

Data Snapshot

• Q2 revenue reached ₹255 crore, representing a 26.24% YoY growth compared to ₹202 crore in the prior-year period.
• Acquisition of Arya Wellness Centre in Guwahati, Assam finalized for ~₹46 crore to expand presence into North-East India.

What's Changed

• Q2 revenue expanded from ₹202 crore in the prior-year period to ₹255 crore (≈26.24% YoY growth, derived: ₹255 crore vs ₹202 crore).
• Strategic geographic footprint widened into North-East India via the ~₹46 crore acquisition of Arya Wellness Centre in Guwahati.

Key Takeaways

• Vijaya Diagnostic delivered robust top-line momentum with Q2 revenue climbing to ₹255 crore.
• Year-on-year revenue grew by 26.24%, supported by core hub stability and network expansion.
• Inorganic expansion via the ~₹46 crore Arya Wellness acquisition strengthens B2C footprint in high-growth non-core geographies.

SAHI Perspective

The top-line growth of 26.24% YoY to ₹255 crore underscores sustained demand in integrated pathology and radiology services. Vijaya Diagnostic's high B2C concentration allows strong pricing leverage and brand recall, while selective bolt-on acquisitions like Arya Wellness Centre provide low-drag entries into new regional markets.

Market Implications

Strong quarterly top-line expansion reinforces investor confidence in diagnostic service providers with integrated business models. Market participants will monitor EBITDA margin retention and integration execution for new regional hubs.

Trading Signals

Market Bias: Bullish

The market bias is positive following a 26.24% YoY increase in Q2 revenue to ₹255 crore from ₹202 crore, combined with disciplined inorganic network expansion in Eastern India.

Overweight: Healthcare Services, Diagnostics & Pathology Chains

Trigger Factors:

• Sustained volume growth in B2C pathology and high-end radiology tests
• Successful integration and ramp-up of the newly acquired Guwahati business
• EBITDA margin stability across newly operational regional hub centers

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian diagnostic sector is witnessing consistent consolidation as organized chains leverage integrated hub-and-spoke infrastructure. B2C-oriented models with strong radiology capabilities offer higher customer stickiness compared to pure B2B pathology setups.

Key Risks to Watch

• Integration delays or higher-than-expected operational costs in newly acquired geographies
• Competitive pricing pressure from regional standalone labs and digital aggregator platforms

Recent Developments

On September 11, 2026, Vijaya Diagnostic Centre announced the 100% acquisition of the integrated diagnostic business of Arya Wellness Centre in Guwahati, Assam, for a total consideration of ~₹46 crore.

Closing Insight

Vijaya Diagnostic's strong revenue expansion of 26.24% YoY demonstrates execution strength in its core markets, while strategic bolt-on deals position the firm for durable multi-region growth.

High Performance Trading with SAHI.